CHIPS Act cash for HP to adapt inkjet tech for life sciences
Briefly

HP Inc will receive $50 million from the US CHIPS Act fund to enhance its microfluidics facility, boosting workforce and technology development for drug discovery.
The investment in HP's semiconductor plant is anticipated to create approximately 150 construction jobs and over 100 manufacturing positions, fostering local economic growth.
Commerce Secretary Gina Raimondo emphasized the importance of the investment in semiconductor technology as a means to maintain US leadership in crucial advancements in life sciences.
HP's CEO Enrique Lores highlighted the transformative potential of microfluidics technology, stating it could lead to revolutionary changes in various sectors including pharmaceuticals.
Read at Theregister
[
|
]